← Back to signals
LH
BUYLaboratory Corporation of America
Health Care
0.88
PEGY ratio
Rank #139
Why This Matters
This stock appears undervalued relative to its growth and dividend yield. Strong projected growth of 72.2% annually over 5 years. Pays a 1.1% dividend yield.
LH trades at 23.0x earnings against 25.0% capped growth (actual 72.2%) + 1.1% yield (PEGY 0.88). Valuation looks favorable — the price is not fully reflecting the growth and yield on offer.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 72.2%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-05-29
Valuation
23.0x
P/E Ratio
Growth
72.2%
5yr EPS
Income
1.1%
Div Yield
PEGY Components
PEGY Score0.88
Denominator26.1%
EPS (TTM)$11.29
Market Data
Price$260.06
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.88→0.88(-0.00)
Rank
#142→#139(+3 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only